Alternatived Products of [ 171178-48-6 ] Product Details of [ 171178-48-6 ]
CAS No. : | 171178-48-6 | MDL No. : | MFCD11044636 |
Formula : |
C7H3Cl2N3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | CKPNVNAKQGYUSK-UHFFFAOYSA-N |
M.W : |
200.02
| Pubchem ID : | 10821876 |
Synonyms : | |
Safety of [ 171178-48-6 ]
Application In Synthesis of [ 171178-48-6 ]
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
- Downstream synthetic route of [ 171178-48-6 ]
- 1
[ 171178-47-5 ] 
[ 171178-48-6 ]
Yield | Reaction Conditions | Operation in experiment |
| With thionyl chloride; N,N-dimethyl-formamide; for 16h;Reflux; | a) Method for synthesising P-1 a:; delta-amino^-chloro-isonicotinic acid (4 g, 23.18 mmol) is taken up in the form of the amide (50 ml.) and stirred for 12 h at 140 0C. The reaction mixture is cooled to RT and mixed with water. The precipitate formed is filtered off, washed with water and then dried at 60 0C for 24h in the vacuum drying cupboard.The intermediate product obtained, 6-chloro-3/-/-pyrido[3,4-c/]pyrimidin-4-one (745 mg, 4.1 mmol), is suspended in thionyl chloride (10 ml_), mixed with one drop of DMF and refluxed for 16 h. The excess thionyl chloride is distilled off. The residue is taken up in DCM, washed 1x with semisaturated NaHCC>;3 solution and saturated NaCI solution, dried on Na2SC>;4 and concentrated to dryness by rotary evaporation. The crude product P-1a is further used directly. |
| With thionyl chloride; N,N-dimethyl-formamide; for 2h;Reflux; | Step 2: containing 20 ml sulfoxide chloride, 1.81 g of 6-chloro-pyrrolo [3,4-d] pyrimidin -4 (3H) - one (10 mmol) and dimethylformamide (catalytic amount ) was heated to reflux for 2 hours, the solvent evaporated the crude product was directly used in the next step without any further purification. |
Reference: [1]Bioorganic and Medicinal Chemistry Letters,2001,vol. 11,p. 1401 - 1405 [2]Journal of Medicinal Chemistry,1996,vol. 39,p. 1823 - 1835 [3]Patent: WO2010/94695,2010,A1 .Location in patent: Page/Page column 35 [4]Journal of Medicinal Chemistry,2014,vol. 57,p. 3484 - 3493 [5]Patent: TWI525093,2016,B .Location in patent: Page/Page column 93 - 2
[ 26807-73-8 ] 
[ 171178-48-6 ] 
[ 202272-97-7 ]
- 3
[ 58483-95-7 ] 
[ 171178-48-6 ]
Reference: [1]Bioorganic and Medicinal Chemistry Letters,2001,vol. 11,p. 1401 - 1405 [2]Journal of Medicinal Chemistry,2014,vol. 57,p. 3484 - 3493 [3]Patent: TWI525093,2016,B [4]ACS Medicinal Chemistry Letters,2018,vol. 9,p. 256 - 261 [5]Bioorganic and Medicinal Chemistry,2018,vol. 26,p. 3619 - 3633 - 4
[ 171178-46-4 ] 
[ 171178-48-6 ]